Insmed | INSM - Interest Expense On Debt

Stock Price
159.72
Daily Change
0.69 0.43%
Monthly
0%
Yearly
106.09%
Q1 Forecast
159.80

Insmed reported $20.6M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
BioMarin Pharmaceutical USD 2.78M 199K Dec/2025
Cytokinetics USD 26.32M 2.06M Sep/2025
DBV Technologies USD 461K 323.71K Mar/2025
Gilead Sciences USD 255M 1000K Dec/2025
Heron Therapeutics USD 500K 900K Sep/2024
Insmed USD 20.6M 217K Dec/2025
Novartis USD 281M 8M Sep/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Sarepta Therapeutics USD 7.56M 2.33M Sep/2025
Ultragenyx Pharmaceutical USD 19M 4.85M Dec/2025
Vertex Pharmaceuticals USD 3.3M 0 Dec/2025